Evidence map›Paper›PMID 29790259›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2018

Monitoring and evaluation framework for hypertension programs. A collaboration between the Pan American Health Organization and World Hypertension League.

Norm R C Campbell, Pedro Ordunez, Donald J DiPette, Gloria P Giraldo, Sonia Y Angell, Marc G Jaffe, Dan Lackland, Ramón Martinez, Yamilé Valdez, Javier I Maldonado Figueredo and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Economic Evaluation of the HEARTS Standardized Hypertension Treatment Program With Fixed-Dose Combination Pills in Chile Primary Care Clinics.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Noncommunicable diseases in the Americas: a review of the Pan American Health Organization's 25-year program of work.Revista panamericana de salud publica = Pan American journal of public health · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 6 countries.

Norm R C CampbellDepartment of Medicine, Physiology and Pharmacology and Community Health Sciences, O'Brien Institute for Public Health and Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, AB, Canada.ORCID 0000-0002-1093-4742
Pedro OrdunezDepartment of Non Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA.
Donald J DiPetteUniversity of South Carolina, University of South Carolina School of Medicine, Columbia, SC, USA.
Gloria P GiraldoDepartment of Non Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA.
Sonia Y AngellNew York City Department of Health and Mental Hygiene, Queens, NY, USA.
Marc G JaffeResolve to Save Lives, an Initiative of Vital Strategies, Cardiovascular Health Initiative, New York, NY, USA.
Dan LacklandMedical University of South Carolina, Charleston, SC, USA.
Ramón MartinezDepartment of Non Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA.
Yamilé ValdezUniversity Hospital "General Calixto García", Havana, Cuba.
Javier I Maldonado FigueredoProfessional Specialized Integrated Management Group for Cardiovascular, Oral Health, Cancer and other Chronic Conditions, Non-Communicable Disease Office, Ministry of Health and Social Protection of Colombia, Bogota, Colombia.
Melanie PaccotMinistry of Health of Chile, Department of Noncommunicable Diseases, División de Control y Prevención de Enfermedades, Ministerio de Salud, Santiago, Chile.
Maria J SantanaDepartments of Pediatrics, Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Paul K WheltonDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
World Health Organization Regional Office for the Americas · USUniversity of Calgary · CAHospital Oncológico Docente "Conrado Benítez García" · CUMedical University of South Carolina · USMinistry of Health · CLMinistry of Health and Social Protection · CONew York City Department of Health and Mental Hygiene · USTulane University · USUniversity of South Carolina · USVital Strategies · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Pan American Health Organization (PAHO)-World Hypertension League (WHL) Hypertension Monitoring and Evaluation Framework is summarized. Standardized indicators are provided for monitoring and evaluating national or subnational hypertension control programs. Five core indicators from the World Health Organization hearts initiative and a single PAHO-WHL core indicator are recommended to be used in all hypertension control programs. In addition, hypertension control programs are encouraged to select from 14 optional qualitative and 33 quantitative indicators to facilitate progress towards enhanced hypertension control. The intention is for hypertension programs to select quantitative indicators based on the current surveillance mechanisms that are available and what is feasible and to use the framework process indicators as a guide to program management. Programs may wish to increase or refine the number of indicators they use over time. With adaption the indicators can also be implemented at a community or clinic level. The standardized indicators are being pilot tested in Cuba, Colombia, Chile, and Barbados.

Indexed as

BarbadosChileColombiaCubaHealth Status IndicatorsHumansHypertensionPan American Health OrganizationPopulation SurveillanceProgram EvaluationWorld Health Organization

Identifiers

PMID29790259
PMCPMC8031273
OpenAlexW2803603591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.